$2.81 -0.10 (%) Cardiome Pharma Corp - NASDAQ

Jan. 23, 2017 | 03:59 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Small Cap Best & Worst Report - Thursday, Jan. 5

    TalkMarkets | Jan. 5, 2017 | 14:04PM EST
  2. Cardiome and SteadyMed Announce Decision for Centralized Review of Trevyent® by the European Medicines Agency

    Benzinga | Jan. 6, 2016 | 08:04AM EST
  3. Cardiome Closes US$23 Million Bought Deal Financing

    GuruFocus | Aug. 13, 2015 | 23:03PM EST
  4. Cardiome Reports ~$15M Bought-Deal Financing

    Benzinga | Jul. 28, 2015 | 15:38PM EST
  5. Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

    Benzinga | Jul. 22, 2015 | 07:05AM EST
  6. SteadyMed and Cardiome Enter into a License Agreement for the Commercialization Rights to Trevyent Outside the U.S.

    Benzinga | Jun. 29, 2015 | 11:00AM EST
  7. Cardiome Pharma Corp. Announces Voting Results

    Benzinga | Jun. 24, 2015 | 07:31AM EST
  8. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Growth Forecast For Next 5 Years

    Benzinga | Jun. 5, 2015 | 03:32AM EST
  9. Cardiome and AOP Orphan Pharma Enter ESMOCARD Commercialization Agreement

    Benzinga | May. 12, 2015 | 07:32AM EST
  10. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip

    Benzinga | Dec. 1, 2014 | 13:43PM EST
  11. Mid-Morning Market Update: Markets Open Lower; Weatherford To Sell Engineered Chemistry, Drilling Fluid Operations to Berkshire's Lubrizol

    Benzinga | Dec. 1, 2014 | 10:23AM EST
  12. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 17:25PM EST
  13. Earnings Scheduled For March 27, 2014

    Benzinga | Mar. 27, 2014 | 04:03AM EST
  14. Benzinga's M&A Chatter for Monday November 18, 2013

    Benzinga | Nov. 18, 2013 | 17:41PM EST
  15. Cardiome Will Buy Correvio LLC, Expecting Deal to Be Immediately Accretive

    Benzinga | Nov. 18, 2013 | 14:20PM EST
  16. Cardiome Reports Commercialization Deal for Brianavess with LifePharma in Cyprus, No Terms Disclosed

    Benzinga | Sep. 24, 2013 | 10:01AM EST
  17. Morning Market Movers

    Benzinga | Sep. 23, 2013 | 09:09AM EST
  18. Cardiome Reports Commercialization Deal with Tazmal Medical Group for Brinavess in Israel

    Benzinga | Sep. 17, 2013 | 12:43PM EST
  19. Cardiome Announces Agreement With Tzamal Medical to Sell Brinavess In Israel

    Benzinga | Sep. 17, 2013 | 12:42PM EST
  20. Benzinga's Small Cap Movers for Tuesday December 11, 2012

    Benzinga | Dec. 11, 2012 | 12:09PM EST
  21. Cardiome Reaches Deal with Merck to Retire Debt/Close Line of Credit; Will Pay Merck $20M

    Benzinga | Dec. 11, 2012 | 01:10AM EST
  22. Merck Returns Rights for Vernakalant to Cardiome

    Benzinga | Sep. 26, 2012 | 01:09AM EST
  23. Cardiome Reports Second Quarter Results

    Benzinga | Aug. 7, 2012 | 13:36PM EST
  24. Cardiome Announces Workforce Reduction

    Benzinga | Jul. 9, 2012 | 02:18AM EST
  25. Cardiome Announces CEO Doug Janzen Has Left Company

    Benzinga | Jul. 3, 2012 | 05:29AM EST
  26. Merck

    IBD | Mar. 19, 2012 | 11:32AM EST
  27. Morning Market Movers

    Benzinga | Dec. 29, 2011 | 02:53AM EST
  28. Microcap Movers for Thursday December 15, 2011

    Benzinga | Dec. 16, 2011 | 01:37AM EST
Trading Center